Corbus Pharmaceuticals is adjusting the primary efficacy outcome of the ongoing and global RESOLVE-1 Phase 3 trial of…
Articles by Alice Melão, MSc
The U.S. Drug Enforcement Administration (DEA) has cleared the use of the active ingredient in EHP-101, an investigational therapy for…
The first patient with diffuse cutaneous systemic sclerosis (SSc) has been given the investigational therapy AVID200 in an ongoing Phase…
Deregulation of the microorganisms that naturally populate the skin is associated with increased inflammation and disease duration in patients with…
People with systemic sclerosis (SSc) are at higher risk for degeneration of a main wrist nerve, a study suggests.
Men are at greater risk of more severe and active systemic sclerosis (SSc) than are women at early stages of…
The analysis of gene profile in blood samples may help identify scleroderma patients who could benefit most from stem cell…
“Don’t Turn a Cold Shoulder to Painful Fingers” is the new campaign launched by the Raynaud’s Association to raise…
Evaluating changes in skin pigmentation could be useful for the management of systemic sclerosis (SSc) patients, particularly to identify those…
A case of acute renal crisis was reported in a patient with limited cutaneous systemic sclerosis (SSc) positive for…